Thyroid Cancer

1. Front Matter

   Pages I-XX

   PDF

2. Basics

   1. Front Matter

      Pages 1-1

      PDF

   2. The Changing Epidemiology of Thyroid Cancer

      • R. Görges

      Pages 3-25

   3. Histopathology, Immunohistochemistry, and Molecular Biology

      • F. Hofstädter

      Pages 27-53

   4. Familial Differentiated Carcinoma of the Thyroid

      • M. R. Carlisle, I. R. McDougall

      Pages 55-67

   5. The Diagnosis of Thyroid Cancer

      • C. Reiners

      Pages 69-79

   6. The Current Surgical Approach to Non-Medullary Thyroid Cancer

      • O. Gimm, H. Dralle

      Pages 81-89

3. Differentiated Thyroid Cancer

   1. Front Matter

      Pages 91-91

      PDF

   2. Radioiodine Therapy for Thyroid Cancer

      • M. Dietlein, D. Moka, H. Schicha

      Pages 93-120

   3. Percutaneous Radiation Therapy

      • C. Puskás, M. Biermann, N. Willich, O. Schober

      Pages 121-129

   4. Thyroid Cancer: Treatment with Thyroid Hormone

      • P.-M. Schumm-Draeger

      Pages 131-138

   5. Treatment with Cytotoxic Drugs

      • B. Saller

      Pages 139-151

   6. Redifferentiation Therapy of Thyroid Carcinomas with Retinoic Acid

      • D. Simon

      Pages 153-163

   7. Follow-up of Patients with Well-Differentiated Thyroid Cancer

      • B. Shapiro, M. D. Gross

      Pages 165-180

   8. Functional Imaging of Thyroid Cancer

      • F. Grünwald

      Pages 181-192

   9. Magnetic Resonance Imaging

      • J. H. Risse

      Pages 193-224

   10. Thyroid Cancer in Chernobyl Children

       • C. Reiners, J. Biko, E. P. Demidchik, V. Drozd

       Pages 225-235

4. Medullary Thyroid Cancer

   1. Front Matter

      Pages 237-237

      PDF

   2. Diagnosis of Medullary Thyroid Cancer

      • F. Raue

      Pages 239-249

   3. Imaging in Medullary Thyroid Cancer

      • T. M. Behr, W. Becker

      Pages 251-273

Thyroid cancer was first described at the end of the eighteenth cen­ tury. For one and a half centuries surgery remained the only effective therapeutic option for this cancer, until in 1946 radioiodine therapy was performed for the first time. Radioiodine therapy was brought to Germany 4 years later, in 1950. In the intervening 50 years, the use of iodine-131 has proved able to cure the cancer and its metastases. Per­ cutaneous radiation therapy had been added to the therapeutic ar­ mamentarium, but even now there is heated debate as to its potential. Suppressive 1-thyroxine supplement is a prerequisite for successful treatment, while cytotoxic drugs are mainly used for palliation. During the past 10 years, various new diagnostic and therapeutic approaches have been introduced. High-dose radioiodine therapy as well as redifferentiation therapy with retinoic acid seem beneficial. Diagnostic procedures such as magnetic resonance imaging (MRI), positron emission tomography (PET), as well as isonitriles (MIBI) 201 and thallium ( Tl), have proved useful for the follow-up of thyroid cancer. Two special issues are also discussed in this book. Iodine supple­ mentation in areas of iodine deficiency has led to a change in pathol­ ogy insofar as papillary thyroid cancer (with a better prognosis) has become more frequent than follicular carcinoma. A special chapter is dedicated to thyroid cancer in Chernobyl children.

• Magnetic Resonance Imaging (MRI
• cancer
• carcinoma
• diagnosis
• epidemiology
• histopathology
• hormone
• hormones
• imaging
• magnetic resonance imaging (MRI)
• molecular biology
• pathology
• radiation
• radiation therapy
• thyroid hormone

RAD Magazine, July, 2006: "This latest edition is packed full of facts, updated references and illustrations ... If your everyday care involves thyroid cancer patients, this book is a must."

• Klinik und Poliklinik für Nuklearmedizin, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany

  H.-J. Biersack

• Abteilung für Nuklearmedizin, Universität Frankfurt, Frankfurt am Main, Germany

  F. Grünwald

Policies and ethics